AMCP stands against racial and health care injustice. AMCP is committed to 1) mitigating disparities related to optimal medication use, 2) advancing conversations by calling for pertinent submissions to the Journal of Managed Care + Specialty Pharmacy (JMCP) and conducting partnership forum(s), 3) incorporating health equity goals into the strategic plan, and 4) supporting impactful education and policy.
June 2022 News & Views: Expand Your Professional Network at Nexus 2022; Read the Latest AMCP CEO Blog Post; View the AMCP Summit on Health Disparities on AMCP Learn; Access the Drug Product Pipeline, Today.
This sponsored webinar reviews the potential gene therapy has to sustain blood-clotting ability for people with hemophilia B by addressing the cause of the condition: a faulty gene for FIX.
A webinar that reviews several approved and numerous investigational cell and gene therapies, and discusses potential strategies for cell and gene therapy companies to consider that may help mitigate reimbursement challenges.
June 2022 Legislative & Regulatory Briefing; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar; AMCP Joins Pharmacy Stakeholders Advocating for PHEPharmacy Staffing Flexibility; [Blog] Why PIE and the Prescription Digital TherapeuticsAct Matter: Recap of AMCP Legislative Days.
May 2022 Legislative & Regulatory Briefing; ICYMI: AMCP Policy & Government Relations Agenda Webinar; AMCP Officially Named Healthy People 2030 Champion; ICYMI: Come (Learn) PIE with Me eLearning Days Webinar.